JP2016525572A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016525572A5 JP2016525572A5 JP2016531580A JP2016531580A JP2016525572A5 JP 2016525572 A5 JP2016525572 A5 JP 2016525572A5 JP 2016531580 A JP2016531580 A JP 2016531580A JP 2016531580 A JP2016531580 A JP 2016531580A JP 2016525572 A5 JP2016525572 A5 JP 2016525572A5
- Authority
- JP
- Japan
- Prior art keywords
- dispersible film
- film according
- concentration
- intraoral
- dispersible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 claims 11
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 11
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 11
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 11
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 9
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 9
- 239000007884 disintegrant Substances 0.000 claims 5
- 229920002689 polyvinyl acetate Polymers 0.000 claims 5
- 239000011118 polyvinyl acetate Substances 0.000 claims 5
- 210000000214 Mouth Anatomy 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 239000004014 plasticizer Substances 0.000 claims 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 3
- 150000001860 citric acid derivatives Chemical class 0.000 claims 3
- 239000002270 dispersing agent Substances 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 210000002200 Mouth Mucosa Anatomy 0.000 claims 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 239000002417 nutraceutical Substances 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 229940069328 Povidone Drugs 0.000 claims 1
- 210000003296 Saliva Anatomy 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- 229940075582 Sorbic Acid Drugs 0.000 claims 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 229920003086 cellulose ether Polymers 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000000580 secretagogue Effects 0.000 claims 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- WSWCOQWTEOXDQX-UHFFFAOYSA-N sorbic acid Chemical compound CC=CC=CC(O)=O WSWCOQWTEOXDQX-UHFFFAOYSA-N 0.000 claims 1
- 235000010199 sorbic acid Nutrition 0.000 claims 1
- 239000004334 sorbic acid Substances 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 239000001069 triethyl citrate Substances 0.000 claims 1
- 235000013769 triethyl citrate Nutrition 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
Claims (27)
崩壊剤が、カルボキシメチルセルロースナトリウムであり、ここで口内分散性フィルムにおけるカルボキシメチルセルロースナトリウムの濃度が1〜22重量%であり;
口内分散性フィルムの全構成要素の総重量百分率が100%を超えない、請求項1〜8のいずれか一項に記載の口内分散性フィルム。 Concentration of Po polyvinyl alcohol or hydroxypropylmethyl cellulose in orodispersible film is 1 to 21 wt%; and,
Disintegrant, carboxymethyl a cellulose sodium, wherein a 1 to 22 wt% concentration of sodium carboxymethyl cellulose in orodispersible film;
The intraoral dispersible film according to any one of claims 1 to 8 , wherein the total weight percentage of all components of the intraoral dispersible film does not exceed 100%.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361860516P | 2013-07-31 | 2013-07-31 | |
US61/860,516 | 2013-07-31 | ||
PCT/PT2014/000050 WO2015016727A2 (en) | 2013-07-31 | 2014-07-31 | Oral dispersible films |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016525572A JP2016525572A (en) | 2016-08-25 |
JP2016525572A5 true JP2016525572A5 (en) | 2017-09-07 |
JP6294479B2 JP6294479B2 (en) | 2018-03-14 |
Family
ID=51535496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016531580A Active JP6294479B2 (en) | 2013-07-31 | 2014-07-31 | Oral dispersible film |
Country Status (8)
Country | Link |
---|---|
US (1) | US9603935B2 (en) |
EP (1) | EP3027172B1 (en) |
JP (1) | JP6294479B2 (en) |
CN (1) | CN105682639B (en) |
BR (1) | BR112016002205A2 (en) |
ES (1) | ES2835258T3 (en) |
HK (1) | HK1225624A1 (en) |
WO (1) | WO2015016727A2 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8701671B2 (en) | 2011-02-04 | 2014-04-22 | Joseph E. Kovarik | Non-surgical method and system for reducing snoring |
US9549842B2 (en) | 2011-02-04 | 2017-01-24 | Joseph E. Kovarik | Buccal bioadhesive strip and method of treating snoring and sleep apnea |
US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
US11357722B2 (en) | 2011-02-04 | 2022-06-14 | Seed Health, Inc. | Method and system for preventing sore throat in humans |
US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
CA3044944C (en) * | 2015-11-25 | 2021-06-22 | Tbm Company | Film for oral hemostasis and wound protection |
MX2018012587A (en) * | 2016-04-14 | 2019-03-07 | Sensorion | (+)-azasetron for use in the treatment of ear disorders. |
CN106619577A (en) * | 2016-10-08 | 2017-05-10 | 中国药科大学 | Novel loratadine oral quickly soluble film and preparation method thereof |
RU2751193C2 (en) | 2017-01-11 | 2021-07-12 | Ферринг Б.В. | Fast decoring pharmaceutical composition |
US11154585B2 (en) * | 2017-01-18 | 2021-10-26 | Pharmathen S.A. | Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population |
US20200197366A1 (en) * | 2017-08-08 | 2020-06-25 | Kashiv Biosciences, Llc | Pharmaceutical composition comprising eliglustat |
US11235013B2 (en) * | 2018-09-04 | 2022-02-01 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
US11185526B2 (en) * | 2018-09-04 | 2021-11-30 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
CN108785289A (en) * | 2018-09-06 | 2018-11-13 | 北京太阳升高科医药研究股份有限公司 | Molten film of naratriptan hydrochloride mouth and preparation method thereof |
CN111166730A (en) * | 2018-11-13 | 2020-05-19 | 杨守忠 | Quick-release orally-dissolvable film of amantadine hydrochloride and preparation method and application thereof |
IT201800020185A1 (en) * | 2018-12-19 | 2020-06-19 | Davide Fiumi | FORMULATIONS CONTAINING VITAMIN D3 IN EDIBLE FILM FOR THE TREATMENT OF PATIENTS WITH MALABSORPTION |
CN109793201B (en) * | 2019-03-26 | 2022-08-09 | 武汉轻工大学 | Natural compound sweetener, preparation method thereof and novel extruded gluten |
CN112569208B (en) * | 2019-09-29 | 2023-10-31 | 四川科伦药物研究院有限公司 | Pramipexole dihydrochloride pharmaceutical composition and preparation method thereof |
US20210187858A1 (en) * | 2019-12-18 | 2021-06-24 | Dieu Cam Vuong | Method and system for manufacturing of pharmaceutical formulas in form of orally disintegrating films (odf) |
CN111388455B (en) * | 2020-04-09 | 2022-09-02 | 沈阳药科大学 | Everolimus oral film and preparation method thereof |
US20230330036A1 (en) * | 2022-04-13 | 2023-10-19 | Oak Therapeutics, Inc. | Long acting, continuous oral release from oral dispersing strips (ods) addressing the need for high dosage of active ingredients |
WO2023230430A1 (en) * | 2022-05-21 | 2023-11-30 | Neuvision Development Llc | Topical ocular administration of ambroxol for ocular pain |
CN114886877B (en) * | 2022-06-16 | 2024-02-02 | 北京海泰天正医药科技有限公司 | Olanzapine Ping Fu sittin compound oral solution film and preparation method thereof |
CN114983984B (en) * | 2022-07-26 | 2023-09-01 | 山东达因海洋生物制药股份有限公司 | Compound oral film for treating asthma and preparation method thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2656338B2 (en) * | 1989-01-31 | 1997-09-24 | 日東電工株式会社 | Oral mucosa patch preparation |
DE19961897A1 (en) * | 1999-12-20 | 2001-06-28 | Basf Ag | Use of a film coating as a taste masking coating of pharmaceutical dosage forms |
US6585997B2 (en) * | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
CA2473967C (en) * | 2001-10-12 | 2011-06-14 | Monosolrx Llc | Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made therefrom |
ES2444951T5 (en) | 2001-10-12 | 2022-06-28 | Aquestive Therapeutics Inc | Uniform films for a fast-dissolving dosage form incorporating taste-masking compositions |
CA2523372A1 (en) | 2003-05-02 | 2004-11-11 | Warner-Lambert Company Llc | Fast dissolving orally consumable films containing a modified starch for improved heat and moisture resistance |
EP2161021B1 (en) * | 2007-06-07 | 2017-03-08 | Sato Pharmaceutical Co. Ltd. | Medicinal film preparation with rapidly dissolving property and flexibility |
WO2010086989A1 (en) | 2009-01-29 | 2010-08-05 | 日東電工株式会社 | Intraoral film-shaped base and preparation |
WO2011090694A1 (en) * | 2009-12-28 | 2011-07-28 | Monosol Rx, Llc | Orally administrable film dosage forms containing ondansetron |
RU2562586C2 (en) * | 2010-12-23 | 2015-09-10 | Колгейт-Палмолив Компани | Films and compositions, composing thereof |
-
2014
- 2014-07-31 US US14/448,438 patent/US9603935B2/en active Active
- 2014-07-31 JP JP2016531580A patent/JP6294479B2/en active Active
- 2014-07-31 WO PCT/PT2014/000050 patent/WO2015016727A2/en active Application Filing
- 2014-07-31 BR BR112016002205A patent/BR112016002205A2/en active Search and Examination
- 2014-07-31 ES ES14762113T patent/ES2835258T3/en active Active
- 2014-07-31 EP EP14762113.0A patent/EP3027172B1/en active Active
- 2014-07-31 CN CN201480051761.8A patent/CN105682639B/en active Active
-
2016
- 2016-12-06 HK HK16113913A patent/HK1225624A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2016525572A5 (en) | ||
JP2019147832A5 (en) | ||
US8663659B2 (en) | Orally administrable films | |
JP2010209104A5 (en) | ||
JP5775223B2 (en) | Granules for intraoral rapidly disintegrating tablets | |
JP6067687B2 (en) | Edible oral strip or wafer dosage form containing ion exchange resin for taste masking | |
JP2018100286A (en) | Corticosteroid composition for oral administration | |
JP2007528901A5 (en) | ||
JP2016006108A5 (en) | ||
WO2015016727A4 (en) | Oral dispersible films | |
JP2020523335A5 (en) | ||
RU2017101833A (en) | ORAL DISPOSABLE FILM MEDIUM CONTAINING TADALAFIL AND METHOD FOR PREPARING IT | |
JP2013501717A5 (en) | ||
PT2407166E (en) | Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide | |
JP2009521526A5 (en) | ||
RU2014101990A (en) | LIQUID PHARMACEUTICAL COMPOSITION INCLUDING NITIZINON | |
JP2018516266A5 (en) | ||
US20130039967A1 (en) | Oral dosage forms | |
KR101643572B1 (en) | Orally disintegrating film containing high dose of drugs and method for preparing same | |
JP5952646B2 (en) | Oral dissolution type film preparation | |
JP2016503066A5 (en) | ||
TW201501731A (en) | Enteric coated tablet | |
JP2020510660A5 (en) | ||
FI4138789T3 (en) | New delayed release composition for peroral administration | |
JP2010506855A5 (en) |